[1]陈功森,倪健,罗菊元,等.基于CNKI的冬凌草甲素研究文献计量学分析[J].中国中医药信息杂志,2019,26(9):104-109.[doi:10.3969/j.issn.1005-5304.2019.09.023]
 CHEN Gongsen,NI Jian,LUO Juyuan,et al.Bibliometric Analysis on Study of Oridonin Based on CNKI[J].zhongguo zhongyiyao xinxi zazhi,2019,26(9):104-109.[doi:10.3969/j.issn.1005-5304.2019.09.023]
点击复制

基于CNKI的冬凌草甲素研究文献计量学分析

参考文献/References:

[1] XIE Z, YU H, SUN X, et al. A novel diterpenoid suppresses osteoclastogenesis and promotes osteogenesis by inhibiting Ifrd1- and IκBα-Mediated p65 nuclear translocation[J]. Journal of Bone and Mineral Research,2018,33(4):667-678.

[2] 李春雨,王琪,申珅,等.冬凌草甲素对人黑色素瘤A375细胞侵袭和转移的影响及机制研究[J].中草药,2018,49(3):658-662.

[3] XU J, WOLD E A, DING Y, et al. Therapeutic potential of oridonin and its analogs:from anticancer and antiinflammation to neuroprotection[J]. Molecules,2018,23(2):474.

[4] HUANG W, HUANG M, OUYANG H, et al. Oridonin inhibits vascular inflammation by blocking NF-κB and MAPK activation[J]. European Journal of Pharmacology,2018,826:133-139.

[5] OH H N, SEO J H,LEE M H, et al. Oridonin induces apoptosis in oral squamous cell carcinoma probably through the generation of reactive oxygen species and the p38/JNK MAPK pathway[J]. Int J Oncol,2018,52(5):1749-1759.

[6] 戴一,仲飞.冬凌草甲素的结构修饰与生物活性研究进展[J].有机化学,2017,37(7):1701-1713.

[7] ZHANG Y W, BAO M H, LOU X Y, et al. Effects of oridonin on hepatic cytochrome p450 expression and activities in PXR-humanized mice[J]. Biol Pharm Bull,2018,41(5):707-712.

[8] DING Y, LI D, DING C, et al. Regio- and stereospecific synthesis of oridonin d-ring aziridinated analogues for the treatment of triple-negative breast cancer via mediated irreversible covalent warheads[J]. Journal of Medicinal Chemistry,2018,61(7):2737- 2752.

[9] YANG J, REN X, ZHANG L, et al. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway[J]. Biomed Pharmacother, 2018,100:226-232.

[10] 徐蕴,魏琦,汤大朋,等.2006—2015年中国期刊全文数据库中医基础理论研究文献计量分析[J].中医杂志,2017,58(5):418-422.

[11] 刘劲松.提升学术期刊论文下载与被引频次的思考—基于刊后论文跟踪分析及办刊实践[J].西南石油大学学报:社会科学版,2016,18(4):63-68.

[12] 刘建勋.中药新药药效学实验研究方法与要求[J].中药新药与临床药理,1998,9(2):49-52.

[13] DING, Y, DING C Y, YE N, et al. Discovery and development of natural product oridonin-inspired anticancer agents[J]. Eur J Med Chem,2016,122:102-117.

相似文献/References:

[1]田瑞,刘宁.基于文献计量学的名老中医经验传承研究文献分析[J].中国中医药信息杂志,2011,18(1):28.[doi:10.3969/j.issn.1005-5304.2011.01.011]
 TIAN Rui,LIU Ning.Bibliometric Analysis of Prominent TCM Doctors Experience Researches[J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):28.[doi:10.3969/j.issn.1005-5304.2011.01.011]
[2]王京京,王巧妹,孟宏,等.针灸治疗慢性疲劳综合征施治规律探讨[J].中国中医药信息杂志,2010,17(1):102.
 WANG Jing-jing,WANG Qiao-mei,MENG Hong,et al.Discussion on the Laws of Treatment of Chronic Fatigue Syndrome by Acupuncture and Moxibustion[J].zhongguo zhongyiyao xinxi zazhi,2010,17(9):102.
[3]陈静.国内期刊中医药信息学文献分析[J].中国中医药信息杂志,2010,17(8):95.[doi:10.3969/j.issn.1005-5304.2010.08.055]
[4]陈静,蔡德英.《中国中医药信息杂志》2000-2008年论著文献计量分析[J].中国中医药信息杂志,2009,16(3):98.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):98.
[5]李春梅,邓媛,刘国正.我国中医药期刊发展现状及主要科技核心期刊文献计量分析[J].中国中医药信息杂志,2009,16(6):99.
[6]董燕,崔蒙,李园白.2007年针刺研究领域文献生产力及文献研究特点分析[J].中国中医药信息杂志,2009,16(9):91.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):91.
[7]宋玉静,王京京,吴中朝,等.针灸治疗慢性疲劳综合征文献质量评价[J].中国中医药信息杂志,2009,16(9):105.
 SONG Yu-jing,WANG Jing-jing,WU Zhong-chao,et al.Evaluation of Literature Quality of Acupuncture in Treatment of Chronic Fatigue Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):105.
[8]姚逸,伍晓丽,杨清林.国内近年糖尿病肾病研究的文献计量学分析[J].中国中医药信息杂志,2009,16(12):92.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):92.
[9]刘树春,何素清.中美中医药类杂志的文献计量学对比分析[J].中国中医药信息杂志,2008,15(1):105.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):105.
[10]刘锋,胡晓梅.加强中医及中西医结合治疗再生障碍性贫血的临床规范化研究[J].中国中医药信息杂志,2007,14(3):97.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(9):97.

备注/Memo

基金项目:国家自然科学基金青年基金(81703715);北京市优秀人才骨干培养计划(2017000020124G295)

更新日期/Last Update:

2019-08-12